biospecimen_aliquot__bcr_aliquot_barcode	tcga-d8-a1x9-01a-12d-a159-09
biospecimen_aliquot__bcr_aliquot_uuid	b5f65c3a-b922-4a81-863d-59b72b08d1bf
biospecimen_aliquot__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_aliquot__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099054616
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-05-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a159
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	0.71
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-d8-a1x9-01a-12d
biospecimen_analyte__bcr_analyte_uuid	4394f5ec-3901-444f-b433-51d57d4001cc
biospecimen_analyte__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_analyte__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-d8-a1x9
biospecimen_diagnostic_slides__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	28ce7849-eec5-4abb-a319-a977a1fd3cd1
biospecimen_normal_control__bcr_patient_barcode	tcga-d8-a1x9
biospecimen_normal_control__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_portion__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_portion__bcr_portion_barcode	tcga-d8-a1x9-01a-12
biospecimen_portion__bcr_portion_uuid	5efe5d1a-4559-4cc3-bab6-8a58f95dfbb6
biospecimen_portion__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_portion__date_of_creation	2011-04-04
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	12
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	10.00
biospecimen_protocol__bcr_analyte_barcode	tcga-d8-a1x9-01a-12d
biospecimen_protocol__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_protocol__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_sample__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_sample__bcr_sample_uuid	eee3738e-89d5-41be-8f9d-564e46b4e065
biospecimen_sample__days_to_collection	399
biospecimen_sample__initial_weight	170
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-d8-a1x9.e69cf3e3-4799-4892-87e9-4291b14a1b9c.pdf
biospecimen_sample__pathology_report_uuid	e69cf3e3-4799-4892-87e9-4291b14a1b9c
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_shipment_portion__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	4672d6c4-b826-4143-887c-464ab4020a6d
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-d8-a1x9-01a-21-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
biospecimen_slide__bcr_sample_barcode	tcga-d8-a1x9-01a
biospecimen_slide__bcr_slide_barcode	tcga-d8-a1x9-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	5e0a9a6f-7590-4912-be93-23dac19f12f0
biospecimen_slide__image_file_name	tcga-d8-a1x9-01a-01-ts1.5e0a9a6f-7590-4912-be93-23dac19f12f0.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	5
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	90
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-d8-a1x9
biospecimen_tumor_sample__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_drug__bcr_drug_barcode	tcga-d8-a1x9-d29432
clinical_drug__bcr_drug_uuid	24e1accd-bb3a-4b2a-8e81-18f3452912aa
clinical_drug__bcr_patient_barcode	tcga-d8-a1x9
clinical_drug__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_drug__form_completion_date	2012-3-19
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin+cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	320
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	197
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	60+600
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-d8-a1x9-f29431
clinical_follow_up__bcr_followup_uuid	7dfb15f7-f9d2-4987-8254-9c11c8ead28e
clinical_follow_up__bcr_patient_barcode	tcga-d8-a1x9
clinical_follow_up__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-19
clinical_follow_up__last_contact_days_to	727
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-d8-a1x9
clinical_nte__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_patient__age_at_diagnosis	66
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-d8-a1x9
clinical_patient__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_patient__birth_days_to	-24417
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	% ihc
clinical_patient__er_positivity_scale_other	>75%
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-5-16
clinical_patient__gender	female
clinical_patient__her2_copy_number	not amplified
clinical_patient__her2_fish_status	negative
clinical_patient__her2_status_by_ihc	indeterminate
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	380
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	23
clinical_patient__lymph_nodes_examined_he_count	3
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1x9
clinical_patient__pr_positivity_define_method	%ihc
clinical_patient__pr_positivity_scale_other	>75%
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	d8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-d8-a1x9
clinical_radiation__bcr_patient_uuid	34a74805-300c-4773-ab59-2085fcc2e6cc
clinical_radiation__bcr_radiation_barcode	tcga-d8-a1x9-r29433
clinical_radiation__bcr_radiation_uuid	104383d3-283e-4d53-aaa0-4a610bb320e7
clinical_radiation__form_completion_date	2012-3-19
clinical_radiation__radiation_adjuvant_fractions_total	20
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	350
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	320
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	4500
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A1X9-01A-12D-A159-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A1X9-01A-12D-A159-09.bed.meta
manually_curated__id	tcga-d8-a1x9-01a-12d-a159-09
manually_curated__md5sum	af6ddb24e5148b2cdd5e97f640ec9625
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	b5f65c3a-b922-4a81-863d-59b72b08d1bf
manually_curated__tumor_tag	brca
